Han S - Search Results

1

Cancer immunology and cancer immunodiagnosis.

Zhang J, Han S, Zhang B, Zhang Y. Zhang J, et al. Among authors: han s. J Immunol Res. 2014;2014:725691. doi: 10.1155/2014/725691. Epub 2014 Aug 21. J Immunol Res. 2014. PMID: 25215308 Free PMC article. No abstract available.

2

Autoantibodies against insulin-like growth factor‑binding protein-2 as a serological biomarker in the diagnosis of lung cancer.

Zhang Y, Ying X, Han S, Wang J, Zhou X, Bai E, Zhang J, Zhu Q. Zhang Y, et al. Among authors: han s. Int J Oncol. 2013 Jan;42(1):93-100. doi: 10.3892/ijo.2012.1699. Epub 2012 Nov 15. Int J Oncol. 2013. PMID: 23165420 Free PMC article.

3

Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis.

Zhu Q, Liu M, Dai L, Ying X, Ye H, Zhou Y, Han S, Zhang JY. Zhu Q, et al. Among authors: han s. Autoimmun Rev. 2013 Oct;12(12):1123-8. doi: 10.1016/j.autrev.2013.06.015. Epub 2013 Jun 24. Autoimmun Rev. 2013. PMID: 23806562 Free PMC article. Review.

4

Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis.

Ying X, Han SX, Wang JL, Zhou X, Jin GH, Jin L, Wang H, Wu L, Zhang J, Zhu Q. Ying X, et al. Diagn Pathol. 2013 Aug 5;8:130. doi: 10.1186/1746-1596-8-130. Diagn Pathol. 2013. PMID: 23915185 Free PMC article.

5

The role of RCAS1 as a biomarker in diagnosing CRC and monitoring tumor recurrence and metastasis.

Han SX, Wang J, Wang LJ, Jin GH, Ying X, He CC, Guo XJ, Zhang JY, Zhang Y, Zhu Q. Han SX, et al. Tumour Biol. 2014 Jun;35(6):6149-57. doi: 10.1007/s13277-014-1814-3. Epub 2014 Mar 21. Tumour Biol. 2014. PMID: 24652591

6

The role of PAM4 in the management of pancreatic cancer: diagnosis, radioimmunodetection, and radioimmunotherapy.

Han S, Jin G, Wang L, Li M, He C, Guo X, Zhu Q. Han S, et al. J Immunol Res. 2014;2014:268479. doi: 10.1155/2014/268479. Epub 2014 Apr 10. J Immunol Res. 2014. PMID: 24818166 Free PMC article. Review.

7

Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma.

Han SX, Bai E, Jin GH, He CC, Guo XJ, Wang LJ, Li M, Ying X, Zhu Q. Han SX, et al. J Immunol Res. 2014;2014:261365. doi: 10.1155/2014/261365. Epub 2014 Apr 22. J Immunol Res. 2014. PMID: 24860833 Free PMC article.

8

Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma.

Han SX, Wang JL, Guo XJ, He CC, Ying X, Ma JL, Zhang YY, Zhao Q, Zhu Q. Han SX, et al. J Immunol Res. 2014;2014:262385. doi: 10.1155/2014/262385. Epub 2014 Apr 17. J Immunol Res. 2014. PMID: 24860834 Free PMC article.

9

The intensity of radiotherapy-elicited immune response is associated with esophageal cancer clearance.

Ma JL, Jin L, Li YD, He CC, Guo XJ, Liu R, Yang YY, Han SX. Ma JL, et al. J Immunol Res. 2014;2014:794249. doi: 10.1155/2014/794249. Epub 2014 May 22. J Immunol Res. 2014. PMID: 24967419 Free PMC article.

10

Autoimmune response to PARP and BRCA1/BRCA2 in cancer.

Zhu Q, Han SX, Zhou CY, Cai MJ, Dai LP, Zhang JY. Zhu Q, et al. Oncotarget. 2015 May 10;6(13):11575-84. doi: 10.18632/oncotarget.3428. Oncotarget. 2015. PMID: 25865228 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,424 results

Search Page

Filters